Androgen receptor-modulatory microRNAs provide insight into therapy resistance and therapeutic targets in advanced prostate cancer
Claire Fletcher(Hammersmith Hospital), Charlotte L. Bevan(Imperial College London)
Cited by 70
Related Papers
Manipulating prohibitin levels provides evidence for an in vivo role in androgen regulation of prostate tumours
|Endocrine Related Cancer|2009|56
The CDK7 inhibitor CT7001 (Samuraciclib) targets proliferation pathways to inhibit advanced prostate cancer
|British Journal of Cancer|2023|24